Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
Souglakos J, Kalykaki A, Vamvakas L, Androulakis N, Kalbakis K, Agelaki S, Vardakis N, Tzardi M, Kotsakis AP, Gioulbasanis J, Tsetis D, Sfakiotaki G, Chatzidaki D, Mavroudis D, Georgoulias V.
Souglakos J, et al. Among authors: mavroudis d.
Ann Oncol. 2007 Feb;18(2):305-10. doi: 10.1093/annonc/mdl392. Epub 2006 Nov 1.
Ann Oncol. 2007.
PMID: 17079693
Free article.
Clinical Trial.